Wyczółkowska J, Czuwaj M, Maśliński C
Department of Biogenic Amines, Polish Academy of Sciences, Lódź, Poland.
Drugs Exp Clin Res. 1992;18 Suppl:35-8.
The ability of Chelidonium majus L. alkaloids derivative Ukrain to induce an anaphylactic sensitization was tested on mice and guinea pigs. The levels of IgE antibody in the mouse sera, and IgG1a, IgG1b as well as IgE antibody levels in guinea pig sera, were evaluated by passive cutaneous anaphylaxis (PCA) tests. Ukrain alone or adsorbed on aluminium hydroxide gel (alum) introduced into BALB/c mice in several subcutaneous injections was unable to stimulate measurable anti-Ukrain IgE antibody response. Moreover, Ukrain introduced together with ovalbumin (OA) into mice in the course of immunization with OA induced lower anti-OA antibody response as compared to the response induced by OA alone. Ukrain adsorbed on alum and injected subcutaneously into guinea pigs did not induce measurable IgG1a, IgG1b and IgE antibody response. The present results suggest that the immunomodulating preparation Ukrain could be therapeutically safe at least as far its inability to induce anaphylaxis is concerned.
在小鼠和豚鼠身上测试了白屈菜生物碱衍生物 Ukrain 诱导过敏致敏的能力。通过被动皮肤过敏反应(PCA)试验评估小鼠血清中 IgE 抗体水平以及豚鼠血清中 IgG1a、IgG1b 和 IgE 抗体水平。单独的 Ukrain 或吸附在氢氧化铝凝胶(明矾)上并通过多次皮下注射引入 BALB/c 小鼠体内,均无法刺激产生可测量的抗 Ukrain IgE 抗体反应。此外,在与卵清蛋白(OA)一起免疫小鼠的过程中引入 Ukrain,与单独由 OA 诱导的反应相比,诱导的抗 OA 抗体反应较低。吸附在明矾上并皮下注射到豚鼠体内的 Ukrain 未诱导出可测量的 IgG1a、IgG1b 和 IgE 抗体反应。目前的结果表明,至少就其无法诱导过敏反应而言,免疫调节制剂 Ukrain 在治疗上可能是安全的。